SCHEMBL1948840

SCHEMBL1948840

COC(=O)c1nc(-c2ccc(Cl)s2)nc(N)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
PKM P14618 3/20 0.43
ALDH1A1 P00352 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PDE4B Q07343 8/20 0.41
RCE1 Q9Y256 1/20 0.41
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PDE4D Q08499 5/20 0.39
MAPT P10636 4/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HTT P42858 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1948263 0.90 KDM4E (0.43) KDM4ESMN1; SMN2PKMALDH1A1L3MBTL1
SCHEMBL1946082 0.87 KDM4E (0.41) KDM4ESMN1; SMN2PKMALDH1A1L3MBTL1
SCHEMBL1946586 0.86 KDM4E (0.41) KDM4ESMN1; SMN2PKMALDH1A1L3MBTL1
SCHEMBL1560063 0.86 NPSR1 (0.48) KDM4ESMN1; SMN2ALDH1A1L3MBTL1PDE4B
SCHEMBL12545477 0.84 KDM4E (0.39) KDM4ESMN1; SMN2PKMALDH1A1L3MBTL1
SCHEMBL1946097 0.84 KDM4E (0.40) KDM4ESMN1; SMN2PKMALDH1A1L3MBTL1
SCHEMBL1561219 0.83 PDE4B (0.44) KDM4ESMN1; SMN2ALDH1A1PDE4BHSD17B10
SCHEMBL1948279 0.81 MAPT (0.47) KDM4ESMN1; SMN2PKMALDH1A1L3MBTL1
SCHEMBL1946343 0.79 IKBKB (0.43) KDM4ESMN1; SMN2PKMALDH1A1L3MBTL1
SCHEMBL2466251 0.79 KDM4E (0.44) KDM4ESMN1; SMN2PKMALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110136666-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-06-09 US disclosed
US-20110136666-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-06-09 US disclosed
US-20110136666-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-06-09 US disclosed
WO-2009138712-A2 CHEMICAL COMPOUNDS SYNGENTA LIMITED (GB) 2009-11-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136666-A1 CHEMICAL COMPOUNDS DDT, PNPO, CYP2W1 KDM4E 2495/4885SMN1; SMN2 2548/4885PKM 2922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.